Allspring Global Investments’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $354M | Buy |
2,291,126
+516,521
| +29% | +$79.8M | 0.59% | 27 |
|
|
2025
Q1 | $259M | Sell |
1,774,605
-33,397
| -2% | -$4.88M | 0.45% | 46 |
|
|
2024
Q4 | $330M | Buy |
1,808,002
+47,221
| +3% | +$8.62M | 0.53% | 32 |
|
|
2024
Q3 | $347M | Buy |
1,760,781
+509,163
| +41% | +$100M | 0.54% | 31 |
|
|
2024
Q2 | $259M | Buy |
1,251,618
+132,802
| +12% | +$27.4M | 0.42% | 44 |
|
|
2024
Q1 | $303M | Sell |
1,118,816
-46,490
| -4% | -$12.6M | 0.47% | 35 |
|
|
2023
Q4 | $275M | Sell |
1,165,306
-29,920
| -3% | -$7.07M | 0.46% | 40 |
|
|
2023
Q3 | $234M | Buy |
1,195,226
+6,398
| +0.5% | +$1.25M | 0.42% | 42 |
|
|
2023
Q2 | $250M | Buy |
1,188,828
+31,963
| +3% | +$6.72M | 0.4% | 41 |
|
|
2023
Q1 | $233M | Buy |
1,156,865
+9,039
| +0.8% | +$1.82M | 0.39% | 47 |
|
|
2022
Q4 | $250M | Buy |
1,147,826
+171,479
| +18% | +$37.4M | 0.43% | 40 |
|
|
2022
Q3 | $192M | Buy |
976,347
+331,084
| +51% | +$65.2M | 0.34% | 49 |
|
|
2022
Q2 | $138M | Buy |
645,263
+610,182
| +1,739% | +$131M | 0.23% | 103 |
|
|
2022
Q1 | $9.96M | Buy |
35,081
+17,734
| +102% | +$5.04M | 0.01% | 882 |
|
|
2021
Q4 | $6.54M | Buy |
+17,347
| New | +$6.54M | 0.01% | 1084 |
|